科学家发现靶向肾上腺素受体的新型小分子激动剂,可以口服且无镇静副作用( 四 )


参考资料:
1.D.Yuan,Z.Liu,J.Kaindl,S.Maeda,J.Zhao,X.Sun,J.Xu,P.Gmeiner,H.Wang,B.K.Kobilka.Activationoftheα2Badrenergicreceptorbythesedativesympatholyticdexmedetomidine.NatureChemicalBiology.2020March09.
2.Fink,E.A.,Xu,J.,Hübner,H.,Braz,J.M.,Seemann,P.,Avet,C.,...&Gmeiner,P.(2022).Structure-baseddiscoveryofnonopioidanalgesicsactingthroughtheα2A-adrenergicreceptor.Science,377(6614),eabn7065.
3.J.Xu,S.Cao,H.Hübner,D.Weikert,G.Chen,Q.Lu,D.Yuan,P.Gmeiner,Z.Liu,&Y.Du.Structuralinsightsintoligandrecognition,activationandsignalingoftheα2Aadrenergicreceptor.ScienceAdvances.2022,March4.返回搜狐 , 查看更多
科学家发现靶向肾上腺素受体的新型小分子激动剂,可以口服且无镇静副作用】责任编辑: